William Cavanagh, Chief R&D Officer at Perspective Therapeutics, holds 27.69K shares in Perspective Therapeutics (Ticker: CATX). Most recently, William Cavanagh Bought $7,692 shares of Perspective Therapeutics on Oct 28, 2020 for an estimated value of 4.00K.